Can we improve the statistical analysis of stroke trials? Statistical re-analysis of functional outcomes in stroke trials

Article English OPEN
Bath, Philip M.W. (2007)

Background: Most large acute stroke trials have been neutral. Functional outcome is usually analysed using a yes or no answer, e.g. death or dependency vs. independence. We assessed which statistical approaches are most efficient in analysing outcomes from stroke trials.\ud \ud Methods: Individual patient data from acute, rehabilitation and stroke unit trials studying the effects of interventions which alter functional outcome were assessed. Outcomes included modified Rankin Scale, Barthel Index, and ‘3 questions’. Data were analysed using a variety of approaches which compare two treatment groups. The results for each statistical test for each trial were then compared.\ud \ud Results: Data from 55 datasets were obtained (47 trials, 54,173 patients). The test results differed substantially so that approaches which use the ordered nature of functional outcome data (ordinal logistic regression, t-test, robust ranks test, bootstrapping the difference in mean rank) were more efficient statistically than those which collapse the data into 2 groups (chi square) (ANOVA p<0.001). The findings were consistent across different types and sizes of trial and for the different measures of functional outcome. \ud \ud Conclusions: When analysing functional outcome from stroke trials, statistical tests which use the original ordered data are more efficient and more likely to yield reliable results. Suitable approaches included ordinal logistic regression, t-test, and robust ranks test.
  • References (31)
    31 references, page 1 of 4

    1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute stroke. N Engl J Med. 1995;333:1581-1587.

    2. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet. 1997;349:1641-1649.

    3. Walker M, Gladman J, Lincoln N, Siemonsma P, Whiteley T. Occupational therapy for stroke patients not admitted to hospital: a randomised controlled trial. The Lancet. 1999;354:278 -280.

    4. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, Xie JX, Warlow C, Peto R; on behalf of the CAST and IST Collaborative Groups. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. Stroke. 2000;31:1240 -1249.

    5. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. The Cochrane Library. Oxford: Update Software; 2002.

    6. The ATLANTIS ECASS and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke trials. The Lancet. 2004; 363:768 - 813.

    7. Walker MF, Leonardi-Bee J, Bath P, Langhorne P, Corr S, Drummond A, Gilbertson L, Gladman JRF, Jongbloed L, Parker C. An individual patient data meta-analysis of randomised controlled trials of community occupational therapy for stroke patients. Stroke. 2004;35:2226 -2232.

    8. Saxena R, Wijnhoud AD, Carton H, Hacke W, Kaste M, Przybelski RJ, Stern KN, Koudstaal PJ. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHB, in acute ischemic stroke. Stroke. 1999;30: 993-996.

    9. Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, Norris J; for the ASSIST Investigators. Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke. 2000;31: 347-354.

    10. Enlimomab acute stroke trial investigators. Use of anti-ICAM-1 therapy in ischemic stroke: results of the enlimomab acute stroke trial. Neurology. 2001;57:1428 -1434.

  • Metrics
    No metrics available
Share - Bookmark